UK approves Novo weight-loss pill to edge open European market - Reuters
UK approves Novo weight-loss pill to edge open European market Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Notable Quotes
"This is a landmark approval, making the UK the first country in Europe to approve Wegovy pill."
— Emil Kongshøj Larsen , Executive
"Weight-loss medication can potentially benefit many patients, and being able to take it in tablet form would certainly be easier than having to inject it."
— Prof Victoria Tzortziou Brown , Academic
"Expanding the range of effective treatments is important in helping people sustainably reduce caloric intakes within an increasingly obesogenic environment."
— Naveed Sattar , Academic
"The announcement was a major step forward in treating obesity, increasing access and enabling millions more people to get treatment."
— Jason Murphy , Executive
Key People
Emil Kongshøj Larsen is the executive vice-president for international operations at Novo Nordisk.
Jason Murphy is the head of pharmacy at Chemist4U.
Naveed Sattar is a professor of cardiometabolic medicine at the University of Glasgow.
Prof Victoria Tzortziou Brown is the president of the Royal College of GPs.
Locations
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxPVzEwbDlKNFYwUWN3bXdKTnZGeUczWEFmZ29wRW1JLU5jQmJPcGdVZWt2MTV3YnRaSDdDc05KZHkzdXJJRWlNY1dhVHlBXzVfVHBLRWgzZHAyUW1vNC1iSkxWTDYxT2JrOVNqNFY4bXZfODhDZWNtWmE2aV92LXdOZl9aWUlQelFLMlliLVo0RWZiNWdLRzYwbndwWTkxcG5HNDVRaE1qN3d3VjAxOG5XaVh3?oc=5" target="_blank">UK approves Novo weight-loss pill to edge open European market</a> <font color="#6f6f6f">Reuters</font>
Novo Nordisk's weight-loss pill has been approved in the UK, intensifying competition in the obesity treatment market as the company seeks to regain its lead against U.S. rival Eli Lilly.
The UK's Medicines and Healthcare products Regulatory Agency has approved the Wegovy weight-loss pill, making it available for private prescription to eligible patients in the UK.
The UK's Medicines and Healthcare products Regulatory Agency has approved the Wegovy weight loss pill, marking a significant milestone in obesity care in the UK.
Similar Stories
Related coverage based on topic and tags
Patients switching to Novo Nordisk's Wegovy pill from shots lose more weight in real-world study - Reuters
Patients switching to Novo Nordisk's Wegovy pill from shots lose more weight in real-world study Reuters
September 30, 2026 at 09:57 AMRegeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial - reuters.com
Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial reuters.com
September 30, 2026 at 10:30 PMExperimental Lilly combination drug tops Zepbound in weight-loss trial - Reuters
Experimental Lilly combination drug tops Zepbound in weight-loss trial Reuters
September 30, 2026 at 05:34 PMNovo Nordisk to license experimental GLP-1 pill from China's Hengrui - Reuters
Novo Nordisk to license experimental GLP-1 pill from China's Hengrui Reuters
September 29, 2026 at 04:47 AMLilly's experimental drug cuts weight by 21% in diabetes trial - reuters.com
Lilly's experimental drug cuts weight by 21% in diabetes trial reuters.com
September 29, 2026 at 10:15 PMUS FDA extends review of Novo Nordisk's hemophilia drug over facility issues - Reuters
US FDA extends review of Novo Nordisk's hemophilia drug over facility issues Reuters
October 2, 2026 at 09:52 PM